6.5 years for $80M NPV5% pre-tax - barely worth the effort particularly for a risky narrow vein underground mine. This asset should be in a private company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025